MedTrace Logo

Study on Registration of Xinyuan Capsule

NCT03197844 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2017-06-23

No results posted yet for this study

Summary

The purpose of this study is get to know what and how Xinyuan capsule in hospital results in drug-induced liver injury or adverse drug reactions from a cohort event monitoring as registration research.

Conditions

  • Coronary Disease

Sponsors & Collaborators

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Yanming Xie, BA · Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Eligibility

Min Age
1 Hour
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-23
Primary Completion
2017-06-23
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03197844 on ClinicalTrials.gov